Matsuda et al. used 89Zr-Df-IAB2M (a radiolabeled anti-PSMA antibody) for the evaluation of brain tumor neovasculature and the possibility of detecting PSMA expression using PET. The gene discussed is FOLH1; the disease is brain neoplasm.